Besides, genetic ablation of P2Y2R attenuates sialadenitis in a mouse model of SS [119], suggesting that targeting the P2Y2R could constitute another effective therapeutic approach to reduce SG inflammation (Figure 2). Here, P2RY2 is linked to synovial sarcoma.